ANI Pharmaceuticals Inc. (ANIP)
$71.92
$-1.33
(-1.82%)
As on 01-Sep-2026 16:00EDT
Market cap
$1,673 Mln
Revenue (TTM)
$978 Mln
P/E Ratio
16
P/B Ratio
2.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.2 %
-
ROCE
-- %
-
Industry P/E
37.32
-
EV/EBITDA
7.9
-
Debt to Equity
1
-
Book Value
$--
-
EPS
$4.9
-
Face value
--
-
Shares outstanding
22,959,488
10 Years Aggregate
CFO
$325.24 Mln
EBITDA
$483.84 Mln
Net Profit
$-25.70 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ANI Pharmaceuticals (ANIP)
| -8.9 | -9.2 | -8.4 | -23.1 | 3.8 | 18.8 | 1.9 |
|
BSE Sensex*
| -10.0 | -2.4 | 2.6 | -5.1 | 5.2 | 5.9 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
ANI Pharmaceuticals (ANIP)
| 42.8 | 0.3 | 37.1 | -12.7 | 58.7 | -52.9 | 37.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
ANI Pharmaceuticals (ANIP)
|
71.9 | 1,672.9 | 978.4 | 105.8 | 17.4 | 18.6 | 16 | 2.8 |
| 17.7 | 6,109.1 | 3,117.6 | 157.4 | 14.7 | -- | 37.3 | 190.1 | |
| 202.8 | 10,424.8 | 776.6 | -191.6 | -17.6 | -223.4 | -- | 129.6 | |
| 76.6 | 14,974.8 | 691.8 | -696.2 | -89.1 | -- | -- | 123.7 | |
| 113.4 | 12,310.3 | 830.8 | 54.9 | 3.2 | 8.1 | 264.8 | 17.9 | |
| 12.2 | 10,087.6 | 332,834.2 | 33,166.6 | 11.1 | 8.9 | 28.8 | 2.5 | |
| 23.9 | 11,971.8 | 5,020.0 | -199.0 | 1.6 | -3 | -- | 1.8 | |
| 284.3 | 5,591.7 | 290.5 | 197.2 | 82.5 | 19.9 | 28.9 | 5.9 | |
| 66.9 | 6,058.9 | 450.9 | 138.6 | 39.1 | 115.6 | 50.1 | 32.1 | |
| 132.1 | 8,865.6 | 431.8 | -136.7 | -30.8 | -30.3 | -- | 21.5 |
Shareholding Pattern
View DetailsAbout ANI Pharmaceuticals (ANIP)
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel,... as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota. Read more
-
President, CEO & Director
Mr. Nikhil Lalwani
-
President, CEO & Director
Mr. Nikhil Lalwani
-
Headquarters
Baudette, MN
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for ANI Pharmaceuticals (ANIP)
What is the current share price of ANI Pharmaceuticals Inc (ANIP) Today?
The share price of ANI Pharmaceuticals Inc (ANIP) is $71.92 (NASDAQ) as of 01-Sep-2026 16:00 EDT. ANI Pharmaceuticals Inc (ANIP) has given a return of 3.76% in the last 3 years.
What is the current PB & PE ratio of ANI Pharmaceuticals Inc (ANIP)?
The P/E ratio of ANI Pharmaceuticals Inc (ANIP) is 16.04 times as on 28-Aug-2026, a 57 discount to its peers’ median range of 37.32 times.
The P/B ratio of ANI Pharmaceuticals Inc (ANIP) is 2.83 times as on 28-Aug-2026, a 63 discount to its peers’ median range of 7.75 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
21.39 |
3.10 |
2024 |
-58.03 |
2.51 |
2023 |
56.43 |
2.32 |
2022 |
-13.71 |
1.94 |
2021 |
-15.34 |
1.82 |
What is the 52 Week High and Low of ANI Pharmaceuticals Inc (ANIP)?
The 52-week high and low of ANI Pharmaceuticals Inc (ANIP) are Rs 99.50 and Rs 70.15 as of 02-Sep-2026.
What is the market cap of ANI Pharmaceuticals Inc (ANIP)?
ANI Pharmaceuticals Inc (ANIP) has a market capitalisation of $ 1,673 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in ANI Pharmaceuticals Inc (ANIP)?
Before investing in ANI Pharmaceuticals Inc (ANIP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.